Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials (Q28202129)

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Selection of reperfusion therapy for individual patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Stenting versus thrombolysis in acute myocardial infarction trial (STAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

One-Year Survival Following Early Revascularization for Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912113-7

7 January 2021

10.1016/S0140-6736(03)12113-7

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_o7lc4ibuqnf5bhyzfe5xrkhapi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o7lc4ibuqnf5bhyzfe5xrkhapi

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12517460

1 reference

Consolidated OpenCitations Corpus – April 2017